| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An Alternative Data Transformation Approach for ADA Cut Point Determination: Why Not Use a Weibull Transformation?
|
Jordan, Gregor
|
|
|
23 |
5 |
|
article
|
| 2 |
An Integrated Analysis of Dostarlimab Immunogenicity
|
Lu, Sharon
|
|
|
23 |
5 |
|
article
|
| 3 |
Deciphering the Dynamic Complexities of the Liver Microenvironment — Toward a Better Understanding of Immune-Mediated liver Injury Caused by Immune Checkpoint Inhibitors (ILICI)
|
Wang, Tao
|
|
|
23 |
5 |
|
article
|
| 4 |
Evidence-Based Guidelines for Drug Interaction Studies: Model-Informed Time Course of Intestinal and Hepatic CYP3A4 Inhibition by Clarithromycin
|
Kapetas, Asha J
|
|
|
23 |
5 |
|
article
|
| 5 |
Exosomes in Atherosclerosis, a Double-Edged Sword: Their Role in Disease Pathogenesis and Their Potential as Novel Therapeutics
|
Patel, Neil
|
|
|
23 |
5 |
|
article
|
| 6 |
Interaction of Commonly Used Oral Molecular Excipients with P-glycoprotein
|
Bajaj, Ruchika
|
|
|
23 |
5 |
|
article
|
| 7 |
Is It Time to Use Modeling of Cellular Transporter Homeostasis to Inform Drug-Drug Interaction Studies: Theoretical Considerations
|
Abbiati, Roberto A.
|
|
|
23 |
5 |
|
article
|
| 8 |
Network-Based Systems Analysis Explains Sequence-Dependent Synergism of Bortezomib and Vorinostat in Multiple Myeloma
|
Nanavati, Charvi
|
|
|
23 |
5 |
|
article
|
| 9 |
Pharmacokinetic Analysis of Peptide-Modified Nanoparticles with Engineered Physicochemical Properties in a Mouse Model of Traumatic Brain Injury
|
Waggoner, Lauren E.
|
|
|
23 |
5 |
|
article
|
| 10 |
Quantitative Systems Pharmacology Modeling of Avadomide-Induced Neutropenia Enables Virtual Clinical Dose and Schedule Finding Studies
|
Abbiati, Roberto A.
|
|
|
23 |
5 |
|
article
|
| 11 |
The Evolution of Single-Cell Analysis and Utility in Drug Development
|
Mitra-Kaushik, Shibani
|
|
|
23 |
5 |
|
article
|
| 12 |
The Nano-War Against Complement Proteins
|
Wang, Zhicheng
|
|
|
23 |
5 |
|
article
|
Journal description